baber/WOPTO huggingface dataset:
Patent IE-35992-L (IE)
Title: Device for insertion into the vagina.
IPC: A61D7/00
Filed: 1972-01-18
Abstract: 1384254 Anchoring devices for reproductive tracts AGROPHYSICS INC 19 Jan 1972 [22 Jan 1971 (3)] 2571/72 Heading A5R An anchoring device 30 for insertion into the tubular reproductive tract of a female animal or human being, comprises cylindrical mounting means 20, and spaced-apart yieldable anchoring means 32 carried by the mounting means and projecting outwardly from the cylindrical surface of the mounting means and being disposed circumferentially about and extending longitudinally of the axis of the mounting means, the anchoring means 32 defining spaced channels between the tract wall and the device for permitting bypass of reproductive-tract fluids. Assemblies may be coupled with the anchoring device for retention in the reproductive tract for a variety of functions including: external visual indication of oestrus; artificial insemination; and the delivery of drugs over a period of time. The yieldable anchoring means 32 are preferably curved resilient strands of nylon or polyethylene. For the purpose of indicating oestrus the anchoring device is provided with an indicator assembly 34 which is releasably mounted on the mounting means 20 of the device and whioh comprises a protective sheath 40 and an internal spring member. A mechanically operated oestrus fluid sensing assembly, not shown, retains the indicator assembly 34 on the mounting means 20, Figure 1 (not shown), and releases it under the action of the spring member upon sensing the presence of oestrus fluid for subsequent expulsion by the animal, Figure 2. The indicator assembly 34 may alternatively be replaced by a dye. In the case of drug administration or artificial insemination the mounting means (112), Figure 9 (not shown), includes a container (120) for the drug or semen and a biassing member in the form of a piston (121) to expel the drug or semen through a duct (124) and into the cervical opening. The piston is activated by means of an expandable material within the housing such as solid carbon dioxide or germinatable seeds in contact with water. In order to maintain semen in a frozen or reduced temperature state liquid nitrogen or solid carbon dioxide is disposed around the semen container. Drugs in solid form may simply be contained in a permeable silicone rubber envelope. Slowly soluble, sublimable or vaporisable coatings or plugs may be used as time delays. For use in cows the anchoring device may also be provided with a cervical anchor assembly, Figure 7 (not shown), including a clamping ring (58) to fit over the projecting annulus of the cervix, and a cylindrical rear member (56) for stimulation of the vaginal sphincter-like muscle.
[GB1384254A]
Patent IE-850115-L (IE)
Title: Hydraulic device for steerable wheels.
IPC: B62D5/26
Filed: 1985-01-18
Abstract: The device is constituted by a member (20) having a cylindrical geometry with a movable element (30) capable of reciprocating or rotary movement and connected to the main steering system (25-28) of the vehicle and capable of generating a fluid pressure which is transmitted to the steering actuator (33,39) on the desired axle (19). 
<??>The device provides a fluid by-pass to a reservoir (42) for a certain range around the position corresponding to the straight travelling condition and thus discharges the pressure generated by small deviations from straight traveling, which occur at relatively high speed and which thus are not transmitted and duplicated on the axle concerned (19) which is thus stabilized, with greater driving safety.
Patent IE-35207-L (IE)
Title: Gas-liquid reaction
IPC: C01B25/40
Filed: 1971-02-03
Abstract: 1319182 Gas/liquid contact PARKSON CORP 19 April 1971 [9 Feb 1970] 21136/71 Heading B1F [Also in Division C1] A method of chemically reacting a gas and a liquid comprises continuously injecting the gas into a confined stream of the liquid flowing at a controlled rate, passing the gasliquid mixture through a tortuous flow path comprising parallel passes within a plate-type reactor to induce turbulence, controlling the temperature and pressure within the flow path to effect complete reaction, and removing the product from the flow path. Figs. 2, 3, 4 illustrate alternative plate reactors for the ammoniation of phosphoric acid, indicated diagrammatically as 12 in Fig. 1. In Fig. 2 phosphoric acid of 32-72% P 2 O 5 content enters preheat zone 15 at line 11 and takes a flow path comprised by adjacent parallel passes 13 between plates 14, steam being supplied through three alternate passes 16 to heat the walls of the two intervening passes 13. Optionally the acid may be partially pre-ammoniated at entry. The acid then passes from preheat zone 15 to reaction cone 17, ammonia being injected into the stream at point 18 between the zones by means of an injection plate. The mixture then takes a tortuous flow path through zone 17 as shown by the arrowed lines. Reaction occurs with the evolution of water vapour, and a stream comprising water vapour, molten ammonium polyphosphate and unreacted NH 3 , if any, accelerates towards outlet 19. As in Fig. 1, this stream passes to cyclone separator 20 which discharges the phosphate at line 21 and the gases at 22. The gaseous effluent may be scrubbed with feed acid to extract unreacted NH 3 . In Fig. 3 (not shown) a further injection plate 23 is inserted after zone 17 to introduce water to quench the product and produce an aqueous fertiliser solution directly. From plate 23 the mixture enters cooling zone 24 comprising two passes 25 through which coolant circulates to cool intervening pass 26. In Fig. 4 (not shown) there is no preheat zone and the first plate is an injection plate through which NH 3 is injected into the superphosphoric acid entering at 30. The passes 31 comprising the reaction zone are cooled by alternate cooling passes 32 to prevent the polyphosphate reverting to orthophosphate. A composite fertiliser may be produced by injecting water, clay, potassium solutions and micronutrients at plate 33. The product then passes through cooling pass 34 and out of the reactor.
[GB1319182A]
Patent IE-790166-L (IE)
Title: Coffee brewer structure
IPC: A47J31/54
Filed: 1979-01-30
Abstract: A coffee brewer structure has an elevated temperature heating device for heating water to a brewing temperature, the outlet of the heating device being connected through an elastomeric duct 26 to a distributor 27 arranged to deliver the brewing water in distributed fashion into a brewing chamber. The temperature of the distributor is maintained at a temperature less than that of the heating device as a result of the thermal insulating characteristics of the elastomeric duct for improved functioning of the brewer. The duct is illustratively formed of silicon rubber and extends below the heating device. <IMAGE>
[GB2020790A]
Patent IE-42634-L (IE)
Title: Production of microorganisms
IPC: C12N1/32
Filed: 1976-02-09
Abstract: 1528011 Continuous cultivation of bacteria &c on methanol &c SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ BV 9 Feb 1976 [11 Feb 1975] 5747/75 Heading C6F In a process for the production of microorganisms involving continuously cultivating one or more hydrocarbon or oxygenated hydrocarbon utilizing micro-organisms under aerobic conditions in a liquid growth medium comprising assimilable sources of nitrogen and essential mineral salts in the presence of a hydrocarbon or oxygenated hydrocarbon, withdrawing from the growing culture, liquid growth medium containing micron organisms, separating micro-organisms from the withdrawn liquid growth medium and recycling at least part of the withdrawn liquid growth medium to the growing culture, the withdrawn liquid growth medium is chilled to a temperature in the range of -5 to +20C prior to, or during, the separation of the micro-organisms. It is stated that any buildup of growth-inhibiting material during the separation stage is avoided and contamination of the separation and recycle lines by undesirable anaerobic micro-organisms is discouraged as a result of the chilling. The hydrocarbon or oxygenated hydrocarbon may for example be natural gas, methane or methanol. The Examples relate to the continuous cultivation of a mixed culture of microorganisms comprising a methanol-utilizing bacterium and four non-methanol utilizing bacteria in methanolic culture medium, with recycle of the culture medium and recovery of the micro-organisms produced. The cultivation temperature was 40 or 42C and the chilling temperature 0C. Growth inhibition was encountered when recycling took place without the chilling according to the invention.
[GB1528011A]
Patent IE-39017-L (IE)
Title: Transporting and launching an offshore tower
IPC: E02B17/02
Filed: 1974-02-18
Abstract: A method and apparatus for transporting and launching an offshore tower. The apparatus comprises a watertight buoyancy system for supporting an offshore tower in a generally horizontal transporting posture substantially above the surface of a body of water and subsequently for controllably righting the offshore tower onto the bed of the body of water at a preselected marine site.
[US3859804A]
Patent IE-35284-L (IE)
Title: Quinoline derivatives
IPC: C07D211/22
Filed: 1971-03-15
Abstract: 1313963 Quinolyl/quinuclidyl ketones and carbinols; substituted-quinolyl lithium compounds F HOFFMANN-LA ROCHE & CO AG 19 April 1971 [16 March 1970] 24189/71 Headings C2C and C2J The title ketones (VI) and carbinols (I, II): wherein m is 1-or 2, R 1 is H, halogen, OH, CF 3 or C 1-7 alkyl or alkoxy,-or (R 1 ) m is methylenedioxy, and R 2 is vinyl or Et, and their enantiomers, racemates and acid addition salts, are prepared by reacting together the corresponding quinolyl-Li (III) with either an epimeric 2-formyl-5- R 2 -quinuclidine (giving I, II) or an epimeric ester of a 5-R 2 -quinuclidine-2-carboxylic acid (giving VI), and in the latter case optionally reducing VI to give I, II. Compounds III, prepared in examples by reacting a corresponding 4-bromoquinoline (from the 4-hydroxyquinoline with PBr 3 + PoBr 3 ) with LiBu, are (except when R 1 =H) claimed per se. Also described are the optical resolution of XCH 2 CHOHCCl 3 (X=3- ethyl - 4 - pyridyl) and the preparation of YCH 2 CHOHCHCl 2 (Y=3-ethyl- or 3-vinyl-4- piperidyl). Therapeutic compositions for oral, parenteral or rectal administration comprise the above carbinols (I, II), which have antimalarial and antiarrhythmic properties.
[GB1313963A]
Patent IE-31851-L (IE)
Title: Electric arc welding.
IPC: B23K9/09
Filed: 1968-03-28
Abstract: 1,215,892. Welding by fusion. ELEKTRODENFABRIK OERLIKEN BUHRLE AG. 27 March, 1968 [21 April, 1967], No. 14800/68. Heading B3R. In a method of arc welding in an inert atmosphere with a consumable electrode, the welding current comprises four consecutive peaks, providing drop transfer, a first peak 4 at the end of which the current falls to a level insufficient to maintain a steadily burning arc, a second peak 1 during which material is melted and detached from the electrode in one drop 7, a third peak 2 having substantially the same maximum value as the first peak and during which the arc is maintained with minimal electrode melting, and a fourth peak 3 during which the drop is accelerated towards the work and further material is melted at the end of the electrode, the ratio of the maximum values of the second to third peaks being varied between 2À5 : 1 and 10 : 1 and the ratio of the maximum values of the fourth to third peaks being varied between 1À2 : 1 and 7 : 1 in dependence upon electrode diameter and specific current loading. In apparatus (Fig. 4, not shown), for producing the requisite current characteristic, impedances (11, 12) are constructed of cores of grain-oriented laminations whereby the ratio of the maxima of the second to fourth peaks is automatically varied from 4 : 1 to 1 : 1 with increasing mean welding current strength.
[GB1215892A]
Patent IE-34452-L (IE)
Title: Desalted whey product
IPC: A23C1/12
Filed: 1970-04-03
Abstract: 1306402 Whey product AMERICAN HOME PRODUCTS CORP 3 April 1970 [3 April 1969] 15917/70 Heading A2B A process for preparing a high protein calcium-containing desalted whey product comprises (a) desalting whey (e.g. cheese whey) until the ash content is 0.4-0.6% by wt. solids (b) evaporating the desalted whey under vacuum at a temperature up to 155F until the solids content is 40-60% by wt. (c) cooling the evaporated product until at least 40% by wt. of solids content precipitates (d) separating the precipitate from the cooled product (e) adjusting the liquid portion to a pH of 6.0 to 7.5 with calcium hydroxide and (f) drying the adjusted liquid portion with or without prior concentration. The whey subjected to the desalting step may be whey concentrated under vacuum at a temperature up to 165F until the solids content is 20-30% by wt. Step (a) may be carried out using electrodialysis ion exchange, reverse osmosis or colloidal gel fractionation procedures. Step (c) may be carried out gradually with stirring in a number of stages. The solids precipitated comprises lactose. The precipitate may be separated by filtration, decantation or centrifugation. The drying step may use spray-, foam-, or freeze-drying techniques. The whey product may comprise 20-45% milk serum proteins, 50-75% lactose and a mineral content of 2-5% of the milk serum proteins, the mineral content comprising calcium, sodium, phosphorus and chloride. An aqueous solution containing 10% whey product has a pH of 6.0 to 7.5. The whey product may be dissolved in water, mixed with fats (e.g. corn oil and coconut oil), fat-soluble vitamins, sugars, and trace minerals, pasteurised, homogenised, cooled, mixed with water-soluble vitamins and spray dried.
[GB1306402A]
Patent IE-36439-L (IE)
Title: Slurry explosive composition
IPC: C06B47/14
Filed: 1972-04-14
Abstract: 1321731 Explosive compositions IMPERIAL CHEMICAL INDUSTRIES Ltd (B N ROY) 28 March 1972 [3 May 1971] 12735/71 Heading C1D A slurry explosive composition comprises an inorganic oxygen-supplying salt, a solvent for the salt, a polysaccharide thickener, a fuel, and, for aeration of the composition, a nitrogen compound having a specified formula and an oxidizing agent reactable with the nitrogen compound to produce gas. Suitable nitrogen compounds are hydroxylamine and hydrazine and their hydrochlorides, sulphates and nitrates, phenylhydrazine and its hydrochloride and nitrate, 2, 4-dinitrophenylhydrazine, phenylsulphonyl hydrazide, semicarbazide and its hydrochloride and nitrate, phenyl thiosemicarbazide, and benzoyl hydrazide. Preferred oxidising agents are potassium iodate, potassium periodate, copper sulphate, potassium ferricyanide, lead dioxide, ceric ammonium nitrate, potassium permanganate, potassium dichromate, mercuric oxide, hydrogen peroxide, and peroxysulphuric acid. The oxygen-supplying salt may be ammonium, sodium, potassium, barium or calcium nitrate or mixtures thereof. Suitable solvents are water, formamide, dimethylsulphoxide, and ethylene glycol. Fuels referred to are Al, Al Alloy, Si, ferrosilicon, ferrophosphorus, sulphur, carbon, sugar, urea, thiourea, TNT, PETN, RDX, smokeless powder, nitrocellulose, and nitrostarch. Suitable thickeners are carboxymethyl cellulose, guar gum, carob seed gum, karaya gum, locust bean gum, hydroxyethyl cellulose, tamarind flour, and starch. Cross-linking agents may be added, for example potassium pyroantimonate, zinc chromate, or sodium or potassium dichromate in conjuction with potassium antimony tartrate. Other ingredients used in examples are isopropyl nitrate and ethyl centralite.
[GB1321731A]
Patent IE-891142-L (IE)
Title: Gabapentin monohydrate and a process for producing the same
IPC: C07C229/00
Filed: 1989-04-10
Abstract: A novel crystalline form of gabapentin and a novel processes for the small and large scale preparations of the anticonvulsant compound in a highly pure state is disclosed. This novel hydrate is produced by a cost effective process which provides an additional purification stage.
Patent IE-41074-L (IE)
Title: Pharmaceutical preparations for the treatment of¹hypercholesterolaemia
IPC: A61K31/215
Filed: 1975-06-03
Abstract: 1501096 Hypercholesterolaemia treatment BRISTOL - MYERS CO 4 June 1975 [4 June 1974] 24794/74 Addition to 1469457 Heading A5B A pharmaceutical composition for use in the treatment per os of hypercholesterolaemia comprises (a) p-chlorophenoxyisobutyric acid, or the methyl, ethyl, n - propyl or n - butyl ester thereof, or a sodium, potassium, calcium, magnesium, aluminium, zinc, bismuth or iron salt thereof, and (b) one or more ingestible non-toxic aluminium, magnesium or bismuth salts capable of dissolution in human gastrointestinal juices, the total amount of non- toxic metal being from 3.2 to 90 equivalents per mole of α - p - chlorophenoxyisobutyric acid or ester or salt thereof. There may also be present 50 - 8000gm of a basic anion exchange resin per mole of the acid, esters or salt. A method of treating non human mammals is also claimed.
[GB1501096A]
Patent IE-881365-L (IE)
Title: Delivery systems for the controlled administration of lhrh¹analogs
IPC: A61K9/22
Filed: 1988-05-06
Abstract: An implantable polymeric delivery system for the controlled and continuous administration of an LHRH analog which comprises a silicone elastomer matrix in which is dispersed about 30 to about 42 weight percent of water-soluble particulate phase containing an LHRH analog or a pharmaceutically acceptable salt thereof.
Patent IE-39770-L (IE)
Title: Thiazole derivatives
IPC: A61K31/425
Filed: 1974-08-28
Abstract: 1448758 Thiazole derivatives ROUSSEL UCLAF 29 Aug 1974 [29 Aug 1973] 37855/74 Heading C2C Novel compounds I (in which R is C 2-12 alkyl and R1 is H, C 1-8 alkyl or C 1-12 acyl) are prepared by reducing a compound II (in which R1 1 is H or C 1-8 alkyl) to give a compound I in which R1 = H, and, if desired, etherifying or esterifying this compound to give a compound I in which R1 = C 1-8 alkyl or C 1-12 acyl. Compounds II in which R1 1 is C 1-8 alkyl are prepared by esterifying the corresponding acids. Pharmaceutical compositions having hypolipaemic and vasodilatory activity, for oral, rectal or parenteral administration, comprise a compound I together with a pharmaceutical carrier or excipient. (From GB1448758 A) [FR2242094A1]
Patent IE-782082-L (IE)
Title: Microbiological reactor
IPC: C12N1/00
Filed: 1978-10-19
Abstract: A support structure for the growth of biological material from a supply of nutrient comprises one or more bodies, each of which has a substantial voidage within its internal structure and an extensive area of access from its outer surface to the internal voidage. The support structures are suitable for use in fermentation processes and the purification of sewage and industrial effluents.
[GB2006181A]
Patent IE-792108-L (IE)
Title: Process for manufacturing racemic parahydroxymandelic acid
IPC: B01J23/00
Filed: 1979-11-02
Abstract: Racemic parahydroxymandelic acid is prepared by condensing glyoxylic acid with an excess of phenol in water in the presence of an alkaline agent, at 30 to 100 DEG C.
[GB2034308A]
Patent IE-822109-L (IE)
Title: Pneumatic tyre
IPC: C08L9/00
Filed: 1982-08-31
Abstract: Pneumatic tire<1> having a tread<2> composed of (A) medium vinyl polybutadiene rubber, (B) low vinyl polybutadiene rubber and, optionally, (C) cis 1,4-polyisoprene rubber. In a preferential aspect the medium vinyl polybutadiene is required to be of a type prepared by polymerizing 1,3-butadiene with a small amount of divinylbenzene in a hydrocarbon solvent with an alkyl lithium catalyst and in the presence of a polar catalyst modifier.
[EP0074326A1]
Patent IE-862386-L (IE)
Title: Rock bit
IPC: E21B10/56
Filed: 1986-09-08
Abstract: A rock bit has three cones with tunsgten carbide inserts in the cutting structure of each cone. The gage row inserts have a layer of polycrystalline diamond on the converging portion protruding from the surface of the cone. One or more transition layers are provided between the tungsten carbide insert body and the polycrystalline diamond layer. Such a transition layer comprises diamond and precemented tungsten carbide.
[EP0219959A2]
Patent IE-802724-L (IE)
Title: Document scanning
IPC: H01J61/80
Filed: 1980-12-23
Abstract: 1. A light source for scanning a document line-by-line, constituted by a flash tube presenting an inner channel, the ends of which are connected respectively to two gas storage chambers in which are disposed two operating electrodes respectively of the tube, said tube being equipped on the outside with a priming electrode disposed between the two operating electrodes, characterized in that said inner channel is a capillary channel (10) over the useful length of said tube (1) destined to face the document, and that, over the useful length, said tube is a thick-walled tube, the section of which is, for a portion (16) facing the document, substantially formed as a V with a rounded angle in order to form a magnifying glass built into the wall of the tube.
[EP0031556A1]
Patent IE-893537-L (IE)
Title: Sustained release drug-resin complexes
IPC: A61K47/48
Filed: 1989-11-02
Abstract: Disclosed are oral pharmaceutical preparations which comprise a pharmacologically active drug bound to small particles of an ion-exchange resin to provide a drug-resin complex having a drug content above a specified value. The drug-resin complex is subsequently coated with a water-permeable diffusion barrier coating that is insoluble in gastrointestinal fluids thereby providing a controllable sustained release of drug under conditions encountered in the gastrointestinal tract.
Patent IE-893907-L (IE)
Title: Electrical fault detecting device
IPC: G01R11/24
Filed: 1989-12-06
Abstract: An apparatus for determining incorrect usage of an alternating current electricity supply to a metering device, has first signal generating means (26,154), disposed at a first location in the supply, for generating a first signal which varies with a property of the electricity supply in the vicinity of the first location, second signal generating means (28,156), disposed at a second location in the supply, for generating a second signal which varies with a property of the electricity supply in the vicinity of the second location and monitoring and actuator means adapted to monitor the two signals and to produce a third, actuating signal when the first and second signals are inconsistent with a correct electricity supply. The signal generatime means may, for example, comprise a coiled portion (26,28) of one or more cables (L, N) forming part of the supply to produce a magnetic flux signal. Alternatively, or in additon, the signal generating means may comprise a coil (154,156) positioned around a cable (L) forming part of the electricity supply. The signal generating means may also take the form of a device (18,120) for producing a signal which varies with the rotation of a meter disc (114).
Patent NO-832766-L (NO)
Inventor: HAAS HELMUT
IPC: B29C41/30
Filed: 1983-07-29
Abstract: 1. Use of a method for the coating of the surfaces of carboard cut blanks with plastic, in which an extruded plastic foil in viscous state is applied directly on both sides onto individual cardboard cut blanks, characterized in that for the manufacture of files or ring binders, small marginal projections of the foils are produced, which are laid against the side- and front faces of the cut blank.
Patent NO-850199-L (NO)
Inventor: IMMINK KORNELIS ANTONIE SCHOUH
IPC: G11B20/10
Filed: 1985-01-17
Abstract: A method of converting n-bit information words into m-bit code words, and the other way round, is described. The code words have a limited disparity. For every information word two code words are assigned to a group of information words, which code words can be derived from one another by inversion. A choice between these two code words is made to limit the digital sum value so as to obtain a d.c. free code. In order to obtain a further limitation of the digital sum value within the code words these code words are derived from each other by inversion and reversal.